Optimising Prescribing for COPD Patients; What Matters Most?
Respiratory experts Dr Tom Fardon (Consultant Physician), Claire Adams (Nurse Specialist) and Dr Sanjeev Rana (GP) share their experiences and recommendations on what matters most when prescribing inhaler therapy for COPD patients.
Respiratory Nurse, CCG Clinical Lead, Primary Care Clinical Lead for the Respiratory Network in the North East and North Cumbria
Claire Adams is an experienced nurse with a real passion for improving the care of people with Respiratory Disease. Claire has been working in a primary care setting for the past fifteen years. She is the Clinical Lead for Tees Valley CCG and provides Clinical time within that role running a community Respiratory advice service. She recently took the role as the Primary care clinical lead for the Respiratory Network in the North East and North Cumbria and sits on local respiratory network boards both in Durham and Tees where she co-writes local guidelines.
Dr Sanjeev Rana
General Practitioner, Respiratory GPwER, Medical Director, Clinical Commissioner and a Member of the Service Development Committee for the PCRS-UK
Dr Sanjeev Rana is a General Practitioner, Respiratory GPwER, Medical Director, Clinical Commissioner and a Member of the Service Development Committee for the PCRS-UK. He graduated from the Imperial School of Medicine and Technology in 1995 and he has a keen interest in population-based healthcare, applying international healthcare models to optimise healthcare utilisation, developing the NHS workforce and understanding what value means to the NHS.
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on +44 (0)800 221 441